Milestone Scientific (MLSS)

• Market cap: $72.1M
• 1 day: 16.05%
• 5 days: 14.06%
• 1 month: 36.43%
• 3 months: -12.74%
• 6 months: 38.06%
• Year to date: 40.15%
• 1 year: 53.96%
• 5 years: -29.39%
• 10 years: -74.31%
• Sector: Healthcare
• Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies

About: Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.

Employees: 17

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

40% more capital invested

Capital invested by funds: $2.76M [Q2] → $3.86M (+$1.1M) [Q3]

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

6% more funds holding

Funds holding: 34 [Q2] → 36 (+2) [Q3]

0.25% more ownership

Funds ownership: 5.24% [Q2] → 5.49% (+0.25%) [Q3]

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $1.25 35% upside
• Avg. target: $1.25 35% upside
• High target: $1.25 35% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Benchmark Bruce Jackson 45% 1-year accuracy 24 / 53 met price target

35% upside $1.25

Speculative Buy Reiterated

20 Nov 2024